Novo Nordisk y una empresa de biotecnología estadounidense se unen para crear pastillas para la obesidad

Los Ángeles, EE. UU. - 4 de abril de 2023 Novo Nordisk solo editorial Información de stock sobre el logotipo de la fachada de la oficina

(0) comments

Welcome to the discussion.

Keep it Clean. Please avoid obscene, vulgar, lewd, racist or sexually-oriented language.
PLEASE TURN OFF YOUR CAPS LOCK.
Don't Threaten. Threats of harming another person will not be tolerated.
Be Truthful. Don't knowingly lie about anyone or anything.
Be Nice. No racism, sexism or any sort of -ism that is degrading to another person.
Be Proactive. Use the 'Report' link on each comment to let us know of abusive posts.
Share with Us. We'd love to hear eyewitness accounts, the history behind an article.